Bilateral SLN mapping for cervical cancer with ICG and robotic fluorescence imaging is associated with greater accuracy in detecting metastatic disease
A.M. Tran(University of North Carolina at Chapel Hill), Emma Rossi(Indiana University – Purdue University Indianapolis), Lynn D. Kowalski(Las Vegas Institute), L.A. Cantrell(University of Virginia), John F. Boggess(University of Kentucky), Wonhee Yang(University of North Carolina at Chapel Hill), Jennifer Scalici(University of Virginia Health System), Kevin Schuler(St. Elizabeth Healthcare), Rose Hanna(Henry Ford Health System), Anastasia Ivanova(University of North Carolina at Chapel Hill)
Cited by 1
Related Papers
A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study
|The Lancet Oncology|2017|929
Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study
|Journal of Clinical Oncology|2004|644
A comparative study of 3 surgical methods for hysterectomy with staging for endometrial cancer: robotic assistance, laparoscopy, laparotomy
|American Journal of Obstetrics and Gynecology|2008|458
Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations
|Gynecologic Oncology|2017|409
A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas
|New England Journal of Medicine|2015|318